مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

15
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

8
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

COVID-19 and Diabetes.

Pages

  257-263

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
Coronavirus disease 2019 (COVID-19) 

Abstract

 Following the discovery of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in China, it has been transmitted to travelers through respiratory droplets and distributed worldwide. Viral, environmental, and host factors all play a role in getting infected with the virus and having severe forms of the disease named coronavirus disease 2019 (COVID-19). Diabetes is one of the most important Host risk factors in the progression and severity of COVID-19. In Diabetes, hyperglycemia and protein glycosylation increase pro-inflammatory cytokines levels and suppress innate and adaptive immune system by impairing the function of neutrophils, macrophages, and lymphocytes, especially regulatory T lymphocytes. The compromised immune system in diabetic patients makes them vulnerable to infectious diseases like COVID-19. Correspondingly, people with Diabetes are usually treated with angiotensin-converting enzyme (ACE) inhibitors and angiotensin II Type-I receptor blockers (ARBs), which increase ACE2 expression as a receptor for SARS-CoV-2. Thus, diabetic patients are more likely to develop severe forms of COVID-19 and die due to chronic inflammation and impaired immune function.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Asgharzadeh, Vahid, Valiollahzadeh, Mir Reza, Taghinejad, Zahra, ASGHARZADEH, MOHAMMAD, RASHEDI, JALIL, MAHDAVI POOR, BEHROZ, Jalaei Nobari, Hossein, KHALILI, AHMAD ALI, Khairy, Yousof, & Mir Mazhari, Amir Ali. (2023). COVID-19 and Diabetes.. ACTA MEDICA IRANICA, 61(5), 257-263. SID. https://sid.ir/paper/1111944/en

    Vancouver: Copy

    Asgharzadeh Vahid, Valiollahzadeh Mir Reza, Taghinejad Zahra, ASGHARZADEH MOHAMMAD, RASHEDI JALIL, MAHDAVI POOR BEHROZ, Jalaei Nobari Hossein, KHALILI AHMAD ALI, Khairy Yousof, Mir Mazhari Amir Ali. COVID-19 and Diabetes.. ACTA MEDICA IRANICA[Internet]. 2023;61(5):257-263. Available from: https://sid.ir/paper/1111944/en

    IEEE: Copy

    Vahid Asgharzadeh, Mir Reza Valiollahzadeh, Zahra Taghinejad, MOHAMMAD ASGHARZADEH, JALIL RASHEDI, BEHROZ MAHDAVI POOR, Hossein Jalaei Nobari, AHMAD ALI KHALILI, Yousof Khairy, and Amir Ali Mir Mazhari, “COVID-19 and Diabetes.,” ACTA MEDICA IRANICA, vol. 61, no. 5, pp. 257–263, 2023, [Online]. Available: https://sid.ir/paper/1111944/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button